@article{Jain_Malik_Bowry_2018, title={Role of Omega-3 fatty acids in meibomian gland dysfunction}, volume={3}, url={https://opthalmology.medresearch.in/index.php/jooo/article/view/27}, DOI={10.17511/jooo.2018.i04.04}, abstractNote={<p>Objective: To evaluate the role of omega-3 fatty acids in meibomian gland dysfunction (MGD).</p> <p>Design: This was a prospective randomized control study that included patients with MGD attending outpatient Department of Ophthalmology, Subharti Medical College, Meerut.</p> <p>Subjects: 40 patients of both sex above 40 years of age with MGD were included in the study.</p> <p>Methods: Age matched randomization of patients was done in two groups of 20 each. Patients in group A were given 2 capsules of 300mg omega-3 fatty acids for 12 weeks while patients in group B were given a placebo oral supplement. Patients were examined at one-month interval for 3 months after the initial visit. At each visit Ocular Surface Disease Index (OSDI), Schirmer test, Tear film break up time (TBUT), Fluroscein staining and meibum quality score was evaluated.</p> <p>Results: After 3 months we found statistically significant improvement in subjective as well as objective parameters of group A patients (p value &lt; .05) as compared to group B patients.</p> <p>Conclusion: Thus, dietary supplementation with omega-3 fatty acids is an effective treatment modality in meibomian gland dysfunction (MGD).</p&gt;}, number={4}, journal={Tropical Journal of Ophthalmology and Otolaryngology}, author={Jain, Charu and Malik, V.K. and Bowry, Rohan}, year={2018}, month={Dec.}, pages={79-84} }